Imaxio
Chemicals & Related Products · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
99 Rue De Gerland, Lyon, Auvergne-Rhone-...Website
www.imaxio.comRevenue
$5.5 MillionIndustry
About Imaxio
Is Imaxio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Imaxio has new funding data
Product Launch: Get notified when Imaxio launches new products
Click to see if Imaxio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Imaxio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Imaxio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Imaxio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Imaxio is spiking on competitors!
Earning: See what the market has to say on Imaxio recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Imaxio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Imaxio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Imaxio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Imaxio.
Imaxio financials insights
Gather financial insights about Imaxio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Unspecified
$4M
Grant
$7.2M
Grant
$772K
Imaxio Tech Stack
A closer look at the technologies used by Imaxio
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imaxio
IMAXIO is an integrated biotech company focused on immunology. It owns a pipeline of vaccines composed marketed, clinical-stage and preclinical-stage products: Marketed pharmaceuticals: a vaccine against human leptospirosis marketed in France. R&D pipeline based on the IMX313 technology platform: two clinical-stage projects and several preclinical-... Read More